Unravelling thalidomide teratogenicity
Pharmacodynamics
Gaining insight into pain
News in brief
Serotonin biosynthesis block builds bone
Enhancing cognition through PDE4 regulation
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial